Induction and add-on therapy with Mitoxantrone and Interferon beta in multiple sclerosis
Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Gıancarlo Comı(Casa di Cura Columbus), Angelo Ghezzi, S. Baldini(Associazione Italiana Sclerosi Multipla), Annalisa Rizzo(University of Bari Aldo Moro)
Cited by 7
Related Papers
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|706
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624